Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

429
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
429
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

645
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
645
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

718
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

2.6K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.6K
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

585
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
585
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

1.1K
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microbial cell-free DNA for rapid pathogen identification in clinical diagnostics: a proof of concept study.

Genome medicine·2026
Same author

Great debate: surgical aortic valve replacement is first choice for aortic stenosis in patients with a life expectancy beyond 5 years.

European heart journal·2026
Same author

Correction: Comparison of perioperative outcomes of minimally invasive and conventional aortic root surgery in adult patients: a systematic review and meta-analysis.

General thoracic and cardiovascular surgery·2026
Same author

Why Should the Current Generation of Surgical Residents be Academically Active-Lessons From the Past.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

The "Plaque Burden" of Proof: Why Mechanisms Matter in Invasive Coronary Artery Disease Treatment.

European heart journal. Cardiovascular Imaging·2026
Same author

The Impact of Pre-Transplant Ventricular Assist Device Support on Survival After Heart Transplantation in Pediatric Patients: A Systematic Review and Meta-Analysis of Reconstructed Time-To-Event Data.

Pediatric transplantation·2026

Related Experiment Video

Updated: Apr 2, 2026

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.4K

Cardiac Surgery 2025 Reviewed.

Hristo Kirov1, Tulio Caldonazo1, Murat Mukharyamov1

  • 1Department of Cardiothoracic Surgery, Friedrich-Schiller-University of Jena, University Hospital Jena, Jena, Germany.

The Thoracic and Cardiovascular Surgeon
|March 31, 2026
PubMed
Summary
This summary is machine-generated.

Coronary artery bypass grafting (CABG) offers superior long-term outcomes for complex coronary artery disease compared to percutaneous coronary intervention. Transcatheter therapies show promise for mitral/tricuspid disease, but surgery remains optimal for consistent long-term results.

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.0K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Related Experiment Videos

Last Updated: Apr 2, 2026

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training
09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

4.4K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

10.0K
Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.4K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Clinical Evidence Synthesis

Background:

  • Systematic review of cardio-surgical literature for 2025.
  • Focus on randomized and observational evidence in cardiovascular therapies.
  • Analysis of recent guidelines and their impact on treatment decisions.

Purpose of the Study:

  • To provide a results-oriented summary of key cardio-surgical publications from the past year.
  • To evaluate the comparative effectiveness of different treatment modalities for coronary artery disease and valvular heart disease.
  • To inform patient-specific decision-making based on current evidence.

Main Methods:

  • Systematic literature review using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
  • Analysis of randomized trials, meta-analyses, and registry data.
  • Synthesis of evidence regarding coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and transcatheter/surgical valve therapies.

Main Results:

  • Coronary artery bypass grafting (CABG) demonstrates superior long-term outcomes over percutaneous coronary intervention for complex coronary artery disease, primarily due to reduced myocardial infarctions.
  • Atrial fibrillation post-CABG is common but has negligible long-term impact; prolonged dual antiplatelet therapy offers no benefit and increases bleeding risk.
  • Transcatheter mitral/tricuspid valve therapies improve symptoms and quality of life, but surgery provides more consistent long-term outcomes, especially in experienced centers. Controversies exist regarding aortic stenosis treatment guidelines.

Conclusions:

  • Coronary artery bypass grafting remains the preferred strategy for complex coronary artery disease.
  • While transcatheter therapies are advancing for other valve diseases, surgical intervention offers more robust long-term results.
  • Evidence synthesis highlights the ongoing debate and evolving landscape in cardiovascular treatment strategies, emphasizing the need for individualized patient care.